117 related articles for article (PubMed ID: 15899703)
41. The Ionic and hydrophobic interactions are required for the auto activation of cysteine proteases of Plasmodium falciparum.
Sundararaj S; Singh D; Saxena AK; Vashisht K; Sijwali PS; Dixit R; Pandey KC
PLoS One; 2012; 7(10):e47227. PubMed ID: 23077573
[TBL] [Abstract][Full Text] [Related]
42. New insights of falcipain 2 structure from Plasmodium falciparum 3D7 strain.
Chakraborty S; Alam B; Biswas S
Biochem Biophys Res Commun; 2022 Jan; 590():145-151. PubMed ID: 34974303
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum.
Chipeleme A; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem; 2007 Jan; 15(1):273-82. PubMed ID: 17052908
[TBL] [Abstract][Full Text] [Related]
44. Nonpeptidic vinyl and allyl phosphonates as falcipain-2 inhibitors.
Ettari R; Nizi E; Di Francesco ME; Micale N; Grasso S; Zappalà M; Vicík R; Schirmeister T
ChemMedChem; 2008 Jul; 3(7):1030-3. PubMed ID: 18428116
[No Abstract] [Full Text] [Related]
45. Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain.
Ettari R; Zappalà M; Micale N; Schirmeister T; Gelhaus C; Leippe M; Evers A; Grasso S
Eur J Med Chem; 2010 Jul; 45(7):3228-33. PubMed ID: 20434817
[TBL] [Abstract][Full Text] [Related]
46. Design and synthesis of novel 2-pyridone peptidomimetic falcipain 2/3 inhibitors.
Verissimo E; Berry N; Gibbons P; Cristiano ML; Rosenthal PJ; Gut J; Ward SA; O'Neill PM
Bioorg Med Chem Lett; 2008 Jul; 18(14):4210-4. PubMed ID: 18554905
[TBL] [Abstract][Full Text] [Related]
47. Identification of novel parasitic cysteine protease inhibitors by use of virtual screening. 2. The available chemical directory.
Desai PV; Patny A; Gut J; Rosenthal PJ; Tekwani B; Srivastava A; Avery M
J Med Chem; 2006 Mar; 49(5):1576-84. PubMed ID: 16509575
[TBL] [Abstract][Full Text] [Related]
48. Characterization of amino acid variation at strategic positions in parasite and human proteases for selective inhibition of falcipains in Plasmodium falciparum.
Goh LL; Sim TS
Biochem Biophys Res Commun; 2005 Sep; 335(3):762-70. PubMed ID: 16095562
[TBL] [Abstract][Full Text] [Related]
49. Oxidation and Tyrosine Nitration Induce Structural Changes and Inhibits Plasmodium falciparum Falcipain-2 Activity In Vitro.
Bertoldo JB; Terenzi H
Protein Pept Lett; 2016; 23(6):562-72. PubMed ID: 27064097
[TBL] [Abstract][Full Text] [Related]
50. Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents.
Micale N; Kozikowski AP; Ettari R; Grasso S; Zappalà M; Jeong JJ; Kumar A; Hanspal M; Chishti AH
J Med Chem; 2006 Jun; 49(11):3064-7. PubMed ID: 16722625
[TBL] [Abstract][Full Text] [Related]
51. Dipeptide vinyl sultams: synthesis via the Wittig-Horner reaction and activity against papain, falcipain-2 and Plasmodium falciparum.
Valente C; Guedes RC; Moreira R; Iley J; Gut J; Rosenthal PJ
Bioorg Med Chem Lett; 2006 Aug; 16(15):4115-9. PubMed ID: 16697641
[TBL] [Abstract][Full Text] [Related]
52. "Plasmo2D": an ancillary proteomic tool to aid identification of proteins from Plasmodium falciparum.
Khachane A; Kumar R; Jain S; Jain S; Banumathy G; Singh V; Nagpal S; Tatu U
J Proteome Res; 2005; 4(6):2369-74. PubMed ID: 16335988
[TBL] [Abstract][Full Text] [Related]
53. [The role of cysteine protease and cystatin in pathogenesis and laboratory diagnosis of periodontal disease].
Warwas M; Kaczmarek U; Gołab K
Postepy Hig Med Dosw; 2000; 54(6):879-94. PubMed ID: 11227383
[TBL] [Abstract][Full Text] [Related]
54. Substrate mapping and inhibitor profiling of falcipain-2, falcipain-3 and berghepain-2: implications for peptidase anti-malarial drug discovery.
Ramjee MK; Flinn NS; Pemberton TP; Quibell M; Wang Y; Watts JP
Biochem J; 2006 Oct; 399(1):47-57. PubMed ID: 16776649
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of human extracellular cysteine protease inhibitors by the secreted staphylococcal cysteine proteases, staphopain A and B.
Vincents B; Onnerfjord P; Gruca M; Potempa J; Abrahamson M
Biol Chem; 2007 Apr; 388(4):437-46. PubMed ID: 17391065
[TBL] [Abstract][Full Text] [Related]
56. The human protease inhibitor cystatin C is an activating cofactor for the streptococcal cysteine protease IdeS.
Vincents B; Vindebro R; Abrahamson M; von Pawel-Rammingen U
Chem Biol; 2008 Sep; 15(9):960-8. PubMed ID: 18804033
[TBL] [Abstract][Full Text] [Related]
57. Crucial residues in falcipains that mediate hemoglobin hydrolysis.
Pasupureddy R; Verma S; Pant A; Sharma R; Seshadri S; Pande V; Saxena AK; Dixit R; Pandey KC
Exp Parasitol; 2019 Feb; 197():43-50. PubMed ID: 30648557
[TBL] [Abstract][Full Text] [Related]
58. The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site.
Machin JM; Kantsadi AL; Vakonakis I
Malar J; 2019 Dec; 18(1):388. PubMed ID: 31791339
[TBL] [Abstract][Full Text] [Related]
59. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases.
Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M
Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671
[TBL] [Abstract][Full Text] [Related]
60. Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.
Wang SX; Pandey KC; Somoza JR; Sijwali PS; Kortemme T; Brinen LS; Fletterick RJ; Rosenthal PJ; McKerrow JH
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11503-8. PubMed ID: 16864794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
